Oncview

OncView™ features trusted experts who actively address the latest data, practice advice, products, and devices in cancer care. Expert, multidisciplinary oncology providers can engage with these educational offerings to learn about the science driving treatment options.

Updates in the Management of Extensive-Stage Small Cell Lung Cancer

Updates in the Management of Extensive-Stage Small Cell Lung Cancer

May 10th 2021

Considerations for adding immunotherapy to the armamentarium for frontline treatment of extensive-stage small cell lung cancer.

Individualizing Extended Adjuvant Therapy in HR+ Breast Cancer

Individualizing Extended Adjuvant Therapy in HR+ Breast Cancer

May 7th 2021

The current role of genomic testing in HR+ breast cancer and guidance on the use of genomic assays to individualize therapy in the extended adjuvant setting.

MRD and Decision-Making in Early Stage Colorectal Cancer

MRD and Decision-Making in Early Stage Colorectal Cancer

March 26th 2021

Experts focus in on optimizing the use of minimal residual disease as a tool to guide decision making in the adjuvant setting for patients at risk for recurrence with colorectal cancer.

Multiple Myeloma

Therapeutic Advancements in Multiple Myeloma

January 21st 2021

CancerNetwork spoke with Kenneth C. Anderson, MD, about treatment advances in myeloma - from smoldering, newly diagnosed, and relapsed/refractory multiple myeloma.

Lung Cancer

Assessing the Small Cell Lung Cancer Treatment Landscape

January 13th 2021

CancerNetwork spoke with Wade T. Iams, MD, about treatment options available and being evaluated in small cell lung cancer.

<12